University Children's Hospital, University of Wuerzburg, Josef-Schneider-Str. 2, 97080, Wuerzburg, Germany.
Department of Neurology, University of Wuerzburg, Josef-Schneider-Str. 11, 97080, Wuerzburg, Germany.
J Neuroinflammation. 2019 Feb 14;16(1):38. doi: 10.1186/s12974-019-1413-8.
Ureaplasma species (spp.) are commonly regarded as low-virulent commensals but may cause invasive diseases in immunocompromised adults and in neonates, including neonatal meningitis. The interactions of Ureaplasma spp. with host defense mechanisms are poorly understood. This study addressed Ureaplasma-driven cell death, concentrating on apoptosis as well as inflammatory cell death.
Human brain microvascular endothelial cells (HBMEC) were exposed to Ureaplasma (U.) urealyticum serovar 8 (Uu8) and U. parvum serovar 3 (Up3). Resulting numbers of dead cells as well as mRNA levels and enzyme activity of key agents in programmed cell death were assessed by flow cytometry, RNA sequencing, and qRT-PCR, respectively. xCELLigence data were used for real-time monitoring of changes in cell adhesion properties.
Both Ureaplasma isolates induced cell death (p < 0.05, vs. broth). Furthermore, Ureaplasma spp. enhanced mRNA levels for genes in apoptosis, including caspase 3 (Up3 p < 0.05, vs. broth), caspase 7 (p < 0.01), and caspase 9 (Up3 p < 0.01). Caspase 3 activity was increased upon Uu8 exposure (p < 0.01). Vice versa, Ureaplasma isolates downregulated mRNA levels for proteins involved in inflammatory cell death, namely caspase 1 (Uu8 p < 0.01, Up3 p < 0.001), caspase 4 (Uu8 p < 0.05, Up3 p < 0.01), NOD-like receptor pyrin domain-containing 3 (Uu8 p < 0.05), and receptor-interacting protein kinase 3 (p < 0.05).
By inducing apoptosis in HBMEC as main constituents of the blood-brain barrier, Ureaplasma spp. may provoke barrier breakdown. Simultaneous suppression of inflammatory cell death may additionally attenuate host defense strategies. Ultimate consequence could be invasive and long-term CNS infections by Ureaplasma spp.
脲原体(Ureaplasma)种属通常被认为是低毒共生体,但可能在免疫功能低下的成人和新生儿中引起侵袭性疾病,包括新生儿脑膜炎。脲原体与宿主防御机制的相互作用还不太清楚。本研究探讨了脲原体引起的细胞死亡,重点关注细胞凋亡和炎症性细胞死亡。
将人脑微血管内皮细胞(HBMEC)暴露于脲原体(U.)解脲亚种 8 株(Uu8)和 U. parvum 亚种 3 株(Up3)中。通过流式细胞术、RNA 测序和 qRT-PCR 分别评估死亡细胞数量以及程序性细胞死亡关键因子的 mRNA 水平和酶活性。xCELLigence 数据用于实时监测细胞黏附特性的变化。
两种脲原体分离株均诱导细胞死亡(p<0.05,与肉汤相比)。此外,脲原体种属增强了凋亡相关基因的 mRNA 水平,包括半胱天冬酶 3(Up3 p<0.05,与肉汤相比)、半胱天冬酶 7(p<0.01)和半胱天冬酶 9(Up3 p<0.01)。Uu8 暴露后 caspase 3 活性增加(p<0.01)。相反,脲原体分离株下调了参与炎症性细胞死亡的蛋白质的 mRNA 水平,即半胱天冬酶 1(Uu8 p<0.01,Up3 p<0.001)、半胱天冬酶 4(Uu8 p<0.05,Up3 p<0.01)、NOD 样受体富含亮氨酸重复域蛋白 3(Uu8 p<0.05)和受体相互作用蛋白激酶 3(p<0.05)。
脲原体通过诱导血脑屏障主要成分的 HBMEC 细胞凋亡,可能引发屏障破坏。同时抑制炎症性细胞死亡可能会进一步削弱宿主防御策略。最终结果可能是脲原体种属引起的侵袭性和长期中枢神经系统感染。